Rhythm Pharmaceuticals Inc (STU:1RV)
€ 62.04 4.09 (7.06%) Market Cap: 3.83 Bil Enterprise Value: 3.56 Bil PE Ratio: 0 PB Ratio: 349.18 GF Score: 60/100

Rhythm Pharmaceuticals Inc To Discuss Data Presentations Call Transcript

Oct 18, 2023 / 12:00PM GMT
Release Date Price: €21 (-3.67%)

Oct 18, 2023 / 12:00PM GMT
Presentations Call
Oct 18, 2023 / 12:00PM GMT

=====================
Corporate Participants
=====================
* David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications
* David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO

=====================
Conference Call Participants
=====================
* Corinne Jenkins
Goldman Sachs Group, Inc., Research Division - VP
* Dae Gon Ha
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
* Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst
* Michael John Higgins
Ladenburg Thalmann & Co. Inc., Research Division - MD & Senior Biopharmaceuticals Equity Research Analyst
* Philip M. Nadeau
TD Cowen, Research Division - MD

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot